MEDIFAST INC $MED Shares Sold by American Century Companies Inc.

Key Points

• American Century Companies Inc. has reduced its stake in MEDIFAST INC by 7.9%, now holding approximately 2.05% of the company worth $3,032,000 after selling 19,240 shares.
• Several hedge funds have altered their positions in MEDIFAST, with Charles Schwab Investment Management Inc. increasing its stake by 132.7%, now owning 265,572 shares valued at $3,580,000.
• MEDIFAST reported earnings of $0.04 per share, surpassing estimates, and achieved a revenue of $105.56 million for the quarter, which exceeded consensus expectations.

American Century Companies Inc. trimmed its holdings in shares of MEDIFAST INC (NYSE:MED - Free Report) by 7.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 224,945 shares of the specialty retailer's stock after selling 19,240 shares during the quarter. American Century Companies Inc. owned approximately 2.05% of MEDIFAST worth $3,032,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Russell Investments Group Ltd. lifted its position in shares of MEDIFAST by 114.1% in the first quarter. Russell Investments Group Ltd. now owns 19,514 shares of the specialty retailer's stock valued at $267,000 after acquiring an additional 10,401 shares in the last quarter. Nuveen LLC acquired a new stake in shares of MEDIFAST in the first quarter valued at approximately $407,000. Benjamin Edwards Inc. increased its holdings in shares of MEDIFAST by 75.0% in the first quarter. Benjamin Edwards Inc. now owns 24,419 shares of the specialty retailer's stock valued at $329,000 after purchasing an additional 10,469 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of MEDIFAST by 132.7% in the first quarter. Charles Schwab Investment Management Inc. now owns 265,572 shares of the specialty retailer's stock valued at $3,580,000 after purchasing an additional 151,434 shares during the last quarter. Finally, Peapod Lane Capital LLC acquired a new stake in MEDIFAST during the first quarter worth $933,000. 95.51% of the stock is owned by hedge funds and other institutional investors.

MEDIFAST Trading Down 0.4%

MED stock traded down $0.06 during midday trading on Thursday, hitting $13.91. 54,192 shares of the company's stock were exchanged, compared to its average volume of 223,543. The business has a 50-day simple moving average of $13.97 and a two-hundred day simple moving average of $13.67. The stock has a market capitalization of $152.82 million, a PE ratio of 43.45 and a beta of 0.82. MEDIFAST INC has a 1-year low of $11.57 and a 1-year high of $21.98.

MEDIFAST (NYSE:MED - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The specialty retailer reported $0.04 earnings per share for the quarter, beating analysts' consensus estimates of ($0.22) by $0.26. MEDIFAST had a return on equity of 2.00% and a net margin of 0.76%.The business had revenue of $105.56 million during the quarter, compared to analysts' expectations of $96.10 million. MEDIFAST has set its Q3 2025 guidance at -0.600-0.00 EPS. As a group, research analysts expect that MEDIFAST INC will post 0.51 EPS for the current fiscal year.

MEDIFAST Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.